Scott Aaronson

2 presentations

• EFFICACY AND SAFETY OF A SINGLE DOSE OF PSILOCYBIN FOR CHRONIC ACTIVE SUICIDAL IDEATION: EXPERIENCES IN AN OPEN LABEL TRIAL

  2026 ASCP Annual Meeting

• DURABILITY OUTCOMES IN TREATMENT RESISTANT DEPRESSION

  2026 ASCP Annual Meeting